Koselugo 25mg Capsules: A Breakthrough for NF1 Patients with Plexiform Neurofibromas?
Koselugo 25mg Capsules have been recently approved for treating children with Neurofibromatosis Type 1 (NF1) who have plexiform neurofibromas (PNs). This condition can cause significant issues in the lives of children who have it. Does anyone have experience with this medication? What are some of the common side effects and how are there treated? How do they help with the treatment of NF1?
NF1
Koselugo
Plexiform Neurofibromas
amber_sherman · 4/18/20261 min read
last active 4/18/2026
HOT